The EPS projection of Imax Corporation (NYSE:IMAX) for quarter ended 2016-09-30 is $0.16. A week before, the EPS forecast was $0.16 against target of $0.16, a month earlier. This estimate stood at $0.16 60 days earlier versus forecast of $0.16 90 days earlier, confirming a deviation of 0%.
Imax Corporation (NYSE:IMAX) reported that 18 days ago, the positive EPS revisions were 1 and negative revisions at 2.
In last week, the per-share earnings was lowered 0 times and 0 times positively. In last 120, 60, 30 and 90 days the positive revisions were 1, 0, 0 and 0, respectively.
The downgrade of EPS estimates for Imax Corporation (NYSE:IMAX) in the preceding 120, 60, 30 and 90 days were 2, 4, 1 and 4, in that order.
As per the latest update, for the quarter closed 1, the EPS estimate of Imax Corporation (NYSE:IMAX) was $0.16. This projection was computed after accounting 4 calls. As reported on 2016-04-21 the EPS was $0.14. The change was $0.05, demonstrating a percentage deviation of 55.56%. The projections confirmed a standard deviation of 0.02.
Quarterly Sales Estimates
For the fiscal 2017, the yearly sales target for Imax Corporation (NYSE:IMAX) stands at $134.034 and the median estimate at $136.181. Almost 4 analysts announced their estimates.
The highest estimate is $141.775 while the lowest target is $122 showing standard deviation of 8.879%.
As many as 4 analysts released sales estimates reised in upside while 4 reduced sales estimates, demonstrating a deviation of 0%.
In last month, 4 revised sales number projection on upside while 4 lowered the sales target, demonstrating a deviation of 1.905%.
A quarter ago, 4 hiked sales estimations and 4 reduced sales forecast. Imax Corporation (NYSE:IMAX) stated that the change in forecast was 6.486%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...